Contact Us
Global COVID-19 Saliva Screening Test Potential Market Report 2025

COVID-19 Saliva Screening Test Potential Global Market Report 2025 – By Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations), By Technology (Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9), By Mode of Testing (Centralized Testing, Decentralized Testing) – Market Size, Trends, And Global Forecast 2025-2034

COVID-19 Saliva Screening Test Potential Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days Info icon | Format : pdf icon

Need assistance or more information before the purchase?

Enquire Before Buying
COVID-19 Saliva Screening Test Potential Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under COVID-19 Saliva Screening Test Potential Market?

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main locations of COVID-19 saliva screening test potential are travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories, and other locations. Travel stations are designated areas in transportation hubs where individuals can undergo COVID-19 saliva screening tests before embarking on journeys. The various technologies used are fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9 and various modes of testing include centralized testing and decentralized testing.

COVID-19 Saliva Screening Test Potential Market Size and growth rate 2025 to 2029: Graph

What Is The COVID-19 Saliva Screening Test Potential Market Size 2025 And Growth Rate?

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

What Is The COVID-19 Saliva Screening Test Potential Market Growth Forecast?

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of E-Commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

How Is The COVID-19 Saliva Screening Test Potential Market Segmented?

The COVID-19 saliva screening test potential market covered in this report is segmented –

1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations

2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9

3) By Mode Of Testing: Centralized Testing, Decentralized Testing

Subsegments:

1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports

2) By Sports Arenas: Stadiums, Arenas, Event Halls

3) By Entertainment Venues: Theaters, Concert Halls, amusement parks, Nightclubs

4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks

5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas

6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites

7) By Other Locations: Healthcare Facilities, government buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues

What Is Driving The COVID-19 Saliva Screening Test Potential Market? The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market

The increasing healthcare expenditure is expected to propel the growth of the COVID-19 saliva screening test potential market going forward. Healthcare expenditure is the entire amount spent on healthcare-related goods and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. The healthcare expenditure is increasing due to several factors, such as minimally invasive surgeries, cutting-edge diagnostic tools, increase in research and development for new drugs, utilization of healthcare services, and specialty medications. The higher healthcare expenditure can provide the necessary resources and support to leverage the full potential of COVID-19 saliva screening tests, contributing to more effective pandemic management and better public health outcomes. For instance, in 2022, according to the Office for National Statistics, a UK-based national statistics organization on the epilepsy, UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, reflecting a nominal increase of 0.7% compared to spending in 2021. Therefore, the increasing healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential market.

Who Are The Major Players In The Global COVID-19 Saliva Screening Test Potential Market?

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

What Are The Key Trends Of The Global COVID-19 Saliva Screening Test Potential Market? Innovative Data Sharing Platforms Enhancing COVID-19 Saliva Screening And Public Health Preparedness

Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative technologies such as data-sharing platforms to enhance real-time communication and collaboration among healthcare providers, laboratories, and public health authorities, ultimately improving the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable the secure exchange of data among various stakeholders, such as healthcare providers, researchers, and organizations. They facilitate collaboration and information access to improve decision-making, efficiency, and outcomes across sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center focuses on improving strategies for public health emergency response, ensuring that healthcare systems can effectively handle large-scale crises such as pandemics or natural disasters. It aims to enhance the capacity of the Mount Sinai Health System and collaborate with local, regional, and federal partners to develop comprehensive preparedness plans.

What Are Latest Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential Market? Hologic, Inc. Acquires Endomagnetics Ltd. To Strengthen Women's Health Solutions

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. With this acquisition, Hologic, Inc. aims to enhance its portfolio of innovative healthcare solutions and expand its market presence in the women's health sector. Endomagnetics Ltd. is a UK-based medical technology company that manufactures medical devices that help detect cancerous lymph nodes during surgery.

What Is The Regional Outlook For The Global COVID-19 Saliva Screening Test Potential Market?

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the COVID-19 Saliva Screening Test Potential Market?

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the COVID-19 Saliva Screening Test Potential Industry?

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

COVID-19 Saliva Screening Test Potential Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $4.29 billion
Revenue Forecast In 2034 $6.17 billion
Growth Rate CAGR of 9.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing Subsegments: 1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas 6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites 7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. COVID-19 Saliva Screening Test Potential market Characteristics

    3. COVID-19 Saliva Screening Test Potential market Trends And Strategies

    4. COVID-19 Saliva Screening Test Potential market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global COVID-19 Saliva Screening Test Potential Growth Analysis And Strategic Analysis Framework

    5.1. Global COVID-19 Saliva Screening Test Potential PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global COVID-19 Saliva Screening Test Potential market Growth Rate Analysis

    5.4. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global COVID-19 Saliva Screening Test Potential Total Addressable Market (TAM)

    6. COVID-19 Saliva Screening Test Potential market Segmentation

    6.1. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Travel Stations

    Sports Arenas

    Entertainment Venues

    Corporate Campus Environments

    Universities And Colleges

    Factories

    Other Locations

    6.2. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fluorescence-Labelled Antigen

    RT-PCR

    CRISPR-Cas9

    6.3. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Centralized Testing

    Decentralized Testing

    6.4. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Airports

    Train Stations

    Bus Stations

    Seaports

    6.5. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Stadiums

    Arenas

    Event Halls

    6.6. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Theaters

    Concert Halls

    Amusement Parks

    Nightclubs

    6.7. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Offices

    Corporate Campuses

    Business Parks

    6.8. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Higher Education Campuses

    Research Institutions

    Student Housing Areas

    6.9. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Manufacturing Plants

    Production Facilities

    Industrial Sites

    6.10. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Healthcare Facilities

    Government Buildings

    Public Transportation Hubs

    Shopping Centers

    Other Public Or Private Venues

    7. COVID-19 Saliva Screening Test Potential market Regional And Country Analysis

    7.1. Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific COVID-19 Saliva Screening Test Potential market

    8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China COVID-19 Saliva Screening Test Potential market

    9.1. China COVID-19 Saliva Screening Test Potential market Overview

    9.2. China COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India COVID-19 Saliva Screening Test Potential market

    10.1. India COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan COVID-19 Saliva Screening Test Potential market

    11.1. Japan COVID-19 Saliva Screening Test Potential market Overview

    11.2. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia COVID-19 Saliva Screening Test Potential market

    12.1. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia COVID-19 Saliva Screening Test Potential market

    13.1. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea COVID-19 Saliva Screening Test Potential market

    14.1. South Korea COVID-19 Saliva Screening Test Potential market Overview

    14.2. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe COVID-19 Saliva Screening Test Potential market

    15.1. Western Europe COVID-19 Saliva Screening Test Potential market Overview

    15.2. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK COVID-19 Saliva Screening Test Potential market

    16.1. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany COVID-19 Saliva Screening Test Potential market

    17.1. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France COVID-19 Saliva Screening Test Potential market

    18.1. France COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy COVID-19 Saliva Screening Test Potential market

    19.1. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain COVID-19 Saliva Screening Test Potential market

    20.1. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe COVID-19 Saliva Screening Test Potential market

    21.1. Eastern Europe COVID-19 Saliva Screening Test Potential market Overview

    21.2. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia COVID-19 Saliva Screening Test Potential market

    22.1. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America COVID-19 Saliva Screening Test Potential market

    23.1. North America COVID-19 Saliva Screening Test Potential market Overview

    23.2. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA COVID-19 Saliva Screening Test Potential market

    24.1. USA COVID-19 Saliva Screening Test Potential market Overview

    24.2. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada COVID-19 Saliva Screening Test Potential market

    25.1. Canada COVID-19 Saliva Screening Test Potential market Overview

    25.2. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America COVID-19 Saliva Screening Test Potential market

    26.1. South America COVID-19 Saliva Screening Test Potential market Overview

    26.2. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil COVID-19 Saliva Screening Test Potential market

    27.1. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East COVID-19 Saliva Screening Test Potential market

    28.1. Middle East COVID-19 Saliva Screening Test Potential market Overview

    28.2. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa COVID-19 Saliva Screening Test Potential market

    29.1. Africa COVID-19 Saliva Screening Test Potential market Overview

    29.2. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. COVID-19 Saliva Screening Test Potential market Competitive Landscape And Company Profiles

    30.1. COVID-19 Saliva Screening Test Potential market Competitive Landscape

    30.2. COVID-19 Saliva Screening Test Potential market Company Profiles

    30.2.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

    31. COVID-19 Saliva Screening Test Potential market Other Major And Innovative Companies

    31.1. University of North Carolina at Chapel Hill

    31.2. Hologic Inc.

    31.3. Beaumont Health

    31.4. PerkinElmer Inc.

    31.5. Quidel Corporation

    31.6. University of Illinois at Urbana-Champaign

    31.7. Cepheid

    31.8. Seegene Inc.

    31.9. ARUP Laboratories

    31.10. Vatic Health Limited

    31.11. Ambry Genetics Corporation

    31.12. LumiraDx Ltd.

    31.13. Yale School of Public Health

    31.14. Gravity Diagnostics

    31.15. Psomagen Inc.

    32. Global COVID-19 Saliva Screening Test Potential market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential market

    34. Recent Developments In The COVID-19 Saliva Screening Test Potential market

    35. COVID-19 Saliva Screening Test Potential market High Potential Countries, Segments and Strategies

    35.1 COVID-19 Saliva Screening Test Potential market In 2029 - Countries Offering Most New Opportunities

    35.2 COVID-19 Saliva Screening Test Potential market In 2029 - Segments Offering Most New Opportunities

    35.3 COVID-19 Saliva Screening Test Potential market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Roche Diagnostics Corporation Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Abbott Laboratories Financial Performance
  • Table 84: Becton Dickinson and Company Financial Performance
  • Table 85: Danaher Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Roche Diagnostics Corporation Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Abbott Laboratories Financial Performance
  • Figure 84: Becton Dickinson and Company Financial Performance
  • Figure 85: Danaher Corporation Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the COVID-19 Saliva Screening Test Potential market?

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better. For further insights on the COVID-19 Saliva Screening Test Potential market, request a sample here

How will the COVID-19 Saliva Screening Test Potential market drivers and restraints affect the market dynamics? What forces will shape the COVID-19 Saliva Screening Test Potential industry going forward?

The COVID-19 Saliva Screening Test Potential market major growth driver - The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market. For further insights on the COVID-19 Saliva Screening Test Potentia request a sample here

What is the forecast market size or the forecast market value of the COVID-19 Saliva Screening Test Potential market?

The COVID-19 Saliva Screening Test Potential market size has grown strongly in recent years. The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment. The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships. For further insights on the COVID-19 Saliva Screening Test Potential market, request a sample here

How is the COVID-19 Saliva Screening Test Potential market segmented?

The COVID-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
Subsegments:
1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas
6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites
7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues For further insights on the COVID-19 Saliva Screening Test Potential market,
request a sample here

Which region has the largest share of the COVID-19 Saliva Screening Test Potential market? What are the other regions covered in the report?

North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the COVID-19 Saliva Screening Test Potential market, request a sample here.

Who are the major players in the COVID-19 Saliva Screening Test Potential market?

Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative technologies such as data-sharing platforms to enhance real-time communication and collaboration among healthcare providers, laboratories, and public health authorities, ultimately improving the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable the secure exchange of data among various stakeholders, such as healthcare providers, researchers, and organizations. They facilitate collaboration and information access to improve decision-making, efficiency, and outcomes across sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center focuses on improving strategies for public health emergency response, ensuring that healthcare systems can effectively handle large-scale crises such as pandemics or natural disasters. It aims to enhance the capacity of the Mount Sinai Health System and collaborate with local, regional, and federal partners to develop comprehensive preparedness plans.. For further insights on the COVID-19 Saliva Screening Test Potential market, request a sample here.

What are the key trends in the COVID-19 Saliva Screening Test Potential market?

Major trends in the COVID-19 Saliva Screening Test Potential market include Innovative Data Sharing Platforms Enhancing COVID-19 Saliva Screening And Public Health Preparedness. For further insights on the COVID-19 Saliva Screening Test Potential market, request a sample here.

What are the major opportunities in the COVID-19 Saliva Screening Test Potential market? What are the strategies for the COVID-19 Saliva Screening Test Potential market?

For detailed insights on the major opportunities and strategies in the COVID-19 Saliva Screening Test Potential market, request a sample here.

How does the COVID-19 Saliva Screening Test Potential market relate to the overall economy and other similar markets?

For detailed insights on COVID-19 Saliva Screening Test Potential's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the COVID-19 Saliva Screening Test Potential industry?

For detailed insights on the mergers and acquisitions in the COVID-19 Saliva Screening Test Potential industry, request a sample here.

What are the key dynamics influencing the COVID-19 Saliva Screening Test Potential market growth? SWOT analysis of the COVID-19 Saliva Screening Test Potential market.

For detailed insights on the key dynamics influencing the COVID-19 Saliva Screening Test Potential market growth and SWOT analysis of the COVID-19 Saliva Screening Test Potential industry, request a sample here.

Back to top
Back to top